ATG5 — ATG5 Protein

Introduction

Atg5 — Atg5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

ATG5 (Autophagy Related 5) is a protein encoded by a gene located on chromosome 6q21. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. ATG5 plays important roles in neuronal function and is implicated in neurodegenerative diseases.

Structure

ATG5 is a 284-amino acid protein with an N-terminal ubiquitin-like domain and a C-terminal alpha-helical region. The protein contains the ATG12 conjugation site (Lys149) and interfaces with ATG16L1 through its C-terminal region. ATG5 forms a stable 1:1 conjugate with ATG12 through an isopeptide bond between Gly186 of ATG12 and Lys149 of ATG5. The ATG12-ATG5 complex dimerizes to create the functional ATG16L1 binding platform.

Normal Function

ATG5 is a key ubiquitin-like protein essential for autophagosome formation. ATG5 undergoes conjugation with ATG12 (via E1-like enzyme ATG7 and E2-like enzyme ATG10) to form the ATG12-ATG5 conjugate. This conjugate then interacts with ATG16L1 to form the ATG16L1 complex, which localizes to the developing phagophore (isolation membrane) and serves as the E3 ligase for LC3 (MAP1LC3A) lipidation. The lipidation of LC3 promotes membrane expansion and closure. In neurons, ATG5-mediated autophagy is crucial for synaptic plasticity, neuronal development, and clearance of misfolded proteins and damaged organelles. Deficiencies contribute to neurodegenerative disease pathogenesis through impaired protein homeostasis.

Role in Disease

Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease are associated with dysregulation of ATG5. Altered expression or function contributes to disease pathogenesis through various mechanisms including impaired protein homeostasis, calcium dysregulation, and synaptic dysfunction.

Therapeutic Targeting

Therapeutic targeting of ATG5 for neurodegeneration:

• ATG5 modulators: Compounds that enhance ATG5 function to boost autophagic flux

• Gene therapy: AAV-mediated ATG5 expression to restore autophagy in aging neurons

• Autophagy enhancers: Rapamycin and other mTOR inhibitors indirectly enhance ATG5-dependent autophagy

• Combination approaches: ATG5 activation with aggregate-clearing agents

Key Publications

1. Mizushima N, et al. (1998). “A new protein complex required for autophagy.” Nature. ^{1CitationPMID 9861046Open reference}(https://pubmed.ncbi.nlm.nih.gov/9861046/)

2. Kuma A, et al. (2004). “The role of autophagy during the early neonatal period.” Nature. ^{2(2004)2004 · PMID 15533940Open reference}(https://pubmed.ncbi.nlm.nih.gov/15533940/)

3. Nishiyama J, et al. (2020). “ATG5 deficiency in neurons impairs mitophagy.” Nat Neurosci. ^{3(2020)2020 · PMID 32661391Open reference}(https://pubmed.ncbi.nlm.nih.gov/32661391/)

4. Frake RA, et al. (2015). “Autophagy and neurodegeneration.” J Clin Invest. ^{4(2015)2015 · PMID 25652951Open reference}(https://pubmed.ncbi.nlm.nih.gov/25652951/)

Pathway & Interaction Diagram

Interactive diagram showing ATG5 key relationships in the SciDEX knowledge graph (15 connections shown).

flowchart TD
    ATG5(["ATG5"])
    Autophagy["Autophagy"]
    Inflammation["Inflammation"]
    P62(["P62"])
    LC3(["LC3"])
    Als["Als"]
    AUTOPHAGY(["AUTOPHAGY"])
    INFLAMMATION(["INFLAMMATION"])
    AMPK(["AMPK"])

    ATG5 -->|"activates"| Autophagy
    ATG5 -.->|"inhibits"| Inflammation
    ATG5 -->|"associated with"| Autophagy
    ATG5 -->|"activates"| Inflammation
    ATG5 -.->|"inhibits"| Autophagy
    ATG5 -->|"activates"| P62
    ATG5 -->|"activates"| LC3
    ATG5 -->|"activates"| Als
    ATG5 -->|"associated with"| AUTOPHAGY
    ATG5 -->|"activates"| AUTOPHAGY
    ATG5 -->|"activates"| INFLAMMATION
    AUTOPHAGY -->|"activates"| ATG5
    ATG5 -->|"activates"| AMPK
    ATG5 -->|"associated with"| LC3
    AUTOPHAGY -.->|"inhibits"| ATG5

    style ATG5 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

See Also

• Autophagy (for ULK1, ATG5)

• RNA Metabolism (for HNRPM, HNRPU)

• Ion Channels (for TRPM8)

• Amyotrophic Lateral Sclerosis

• Alzheimer’s Disease

• Parkinson’s Disease

Background

The study of Atg5 — Atg5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data